Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Bellerophon Therapeutics (BLPH) stock
Learn how to easily invest in Bellerophon Therapeutics stock.
Bellerophon Therapeutics, Inc is a biotechnology business based in the US. Bellerophon Therapeutics shares (BLPH) are listed on the NASDAQ and all prices are listed in US Dollars. Bellerophon Therapeutics employs 21 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Bellerophon Therapeutics
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – BLPH – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
Bellerophon Therapeutics stock price (NASDAQ: BLPH)Use our graph to track the performance of BLPH stocks over time.
Bellerophon Therapeutics shares at a glance
|Latest market close||$4.14|
|52-week range||$3.79 - $13.87|
|50-day moving average||$4.58|
|200-day moving average||$5.58|
|Wall St. target price||$22.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.09|
Buy Bellerophon Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Bellerophon Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Bellerophon Therapeutics price performance over time
|1 week (2021-07-17)||N/A|
|1 month (2021-06-28)||-24.45%|
|3 months (2021-04-28)||-7.80%|
|6 months (2021-01-24)||N/A|
|1 year (2020-07-24)||N/A|
|2 years (2019-07-24)||N/A|
|3 years (2018-07-24)||N/A|
|5 years (2016-07-24)||N/A|
Bellerophon Therapeutics financials
|Gross profit TTM||$0|
|Return on assets TTM||-51.86%|
|Return on equity TTM||-142.99%|
|Market capitalisation||$41.7 million|
TTM: trailing 12 months
Shorting Bellerophon Therapeutics shares
There are currently 126,801 Bellerophon Therapeutics shares held short by investors – that's known as Bellerophon Therapeutics's "short interest". This figure is 31.8% down from 186,008 last month.
There are a few different ways that this level of interest in shorting Bellerophon Therapeutics shares can be evaluated.
Bellerophon Therapeutics's "short interest ratio" (SIR)
Bellerophon Therapeutics's "short interest ratio" (SIR) is the quantity of Bellerophon Therapeutics shares currently shorted divided by the average quantity of Bellerophon Therapeutics shares traded daily (recently around 396253.125). Bellerophon Therapeutics's SIR currently stands at 0.32. In other words for every 100,000 Bellerophon Therapeutics shares traded daily on the market, roughly 320 shares are currently held short.
However Bellerophon Therapeutics's short interest can also be evaluated against the total number of Bellerophon Therapeutics shares, or, against the total number of tradable Bellerophon Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Bellerophon Therapeutics's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Bellerophon Therapeutics shares in existence, roughly 10 shares are currently held short) or 0.0199% of the tradable shares (for every 100,000 tradable Bellerophon Therapeutics shares, roughly 20 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Bellerophon Therapeutics.
Find out more about how you can short Bellerophon Therapeutics stock.
Bellerophon Therapeutics share dividends
We're not expecting Bellerophon Therapeutics to pay a dividend over the next 12 months.
Have Bellerophon Therapeutics's shares ever split?
Bellerophon Therapeutics's shares were split on a 1:15 basis on 9 February 2020. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Bellerophon Therapeutics shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Bellerophon Therapeutics shares which in turn could have impacted Bellerophon Therapeutics's share price.
Bellerophon Therapeutics share price volatility
Over the last 12 months, Bellerophon Therapeutics's shares have ranged in value from as little as $3.79 up to $13.8713. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Bellerophon Therapeutics's is -0.5256. This would suggest that Bellerophon Therapeutics's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Bellerophon Therapeutics has bucked the trend.
Bellerophon Therapeutics overview
Bellerophon Therapeutics, Inc. , a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its products include INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse that is in Phase 2 clinical trial for the treatment of pulmonary hypertension associated with fibrotic interstitial lung disease; that has completed Phase 2a clinical trial for pulmonary hypertension associated with chronic obstructive pulmonary disease; and that is in Phase 2 dose escalation stage for pulmonary hypertension associated with sarcoidosis, as well as for chronic thromboembolic pulmonary hypertension, pulmonary hypertension associated with pulmonary edema from high altitude sickness, and COVID-19 patients. The company was formerly known as Ikaria Development LLC and changed its name to Bellerophon Therapeutics, Inc. in January 2014. Bellerophon Therapeutics, Inc.
Stocks similar to Bellerophon Therapeutics
Bellerophon Therapeutics in the news
2 Falling Knives to Catch
Hedge Funds Are Coming Back To Bellerophon Therapeutics, Inc. (BLPH)
Frequently asked questionsWhat percentage of Bellerophon Therapeutics is owned by insiders or institutions?
Currently 4.045% of Bellerophon Therapeutics shares are held by insiders and 44.955% by institutions. How many people work for Bellerophon Therapeutics?
Latest data suggests 21 work at Bellerophon Therapeutics. When does the fiscal year end for Bellerophon Therapeutics?
Bellerophon Therapeutics's fiscal year ends in December. Where is Bellerophon Therapeutics based?
Bellerophon Therapeutics's address is: 184 Liberty Corner Road, Warren, NJ, United States, 07059 What is Bellerophon Therapeutics's ISIN number?
Bellerophon Therapeutics's international securities identification number is: US0787713009 What is Bellerophon Therapeutics's CUSIP number?
Bellerophon Therapeutics's Committee on Uniform Securities Identification Procedures number is: 078771102
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy HNC Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert